Chris LoBianco

Stock Analyst at TD Cowen

(n/a)
# 4,941
Out of 5,010 analysts
6
Total ratings
n/a
Success rate
n/a
Average return
Main Sectors:
Top Industries:

Stocks Rated by Chris LoBianco

Novavax
Aug 4, 2026
Rated: Hold
Price Target: $9
Current: $10.82
Upside: -16.82%
Royalty Pharma
Jun 26, 2025
Initiated Coverage: Buy
Price Target: $42
Current: $58.22
Upside: n/a